The current standard of care for patients with nonmetastatic renal cell carcinoma consists of surgical removal of the kidney followed by observation. ❋ Unknown (2008)
No imbalance in cataract adverse events was observed in postmenopausal women with osteoporosis or in women undergoing aromatase inhibitor therapy for nonmetastatic breast cancer. ❋ Unknown (2010)
Ours was the first, to our knowledge, to study molecular differences between nonmetastatic versus metastatic primary tumors and identify and validate a prognostic signature for PDAC. ❋ Jeran K. Stratford Et Al. (2010)
To accomplish this, we compared nonmetastatic (UNC1) with metastatic (NEB) primary PDAC tumors. ❋ Jeran K. Stratford Et Al. (2010)
We profiled and compared nonmetastatic and metastatic primary PDAC tumors and identified a six-gene signature. ❋ Jeran K. Stratford Et Al. (2010)
Yet despite the large body of evidence supporting the efficacy of BCS, studies conducted in the last two decades reported that less than half of all surgically treated patients with nonmetastatic invasive disease received BCS. ❋ Unknown (2009)
We investigated the effects of denosumab, a fully human monoclonal antibody against receptor B ligand, on bone mineral density and fractures in men receiving androgen-deprivation therapy for nonmetastatic prostate cancer. ❋ Unknown (2009)
The test also distinguished metastatic from nonmetastatic disease. ❋ Unknown (2009)
"Men who were physically active after diagnosis of nonmetastatic colorectal cancer-specific death, as well as death from any cause," the authors write. ❋ Unknown (2009)
Patients who initially had nonmetastatic cancer that subsequently metastasized, Stein and colleagues found, had elevated levels of S100A4 mRNA in the initial blood samples as compared with those from patients who did not develop metastatic disease. ❋ Unknown (2009)
Denosumab was associated with increased bone mineral density at all sites and a reduction in the incidence of new vertebral fractures among men receiving androgen-deprivation therapy for nonmetastatic prostate cancer. ❋ Unknown (2009)
"Treatment of nonmetastatic invasive breast cancer has improved significantly over the past several decades, but we continue to fall short of the goal to treat every woman with the highest quality care," said Grace L. Smith, MD, PhD, Postdoctoral Fellow, Department of Radiation Oncology, The University of Texas M. ❋ Unknown (2009)
According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer, there are still significant socioeconomic and geographic disparities in the use of this type of therapy. ❋ Unknown (2009)
Breakthrough testosterone that increases androgen-independent progression has been studied in patients with nonmetastatic prostate cancer receiving medical castration, 38. 4% of whom also received antiandrogen. ❋ Unknown (2009)
